Core Viewpoint - The A-share market has experienced a significant pullback, particularly in the ChiNext index, which fell over 3% amid a broader global market decline, raising questions about future market direction and investment opportunities [2][4]. Group 1: Market Performance - The A-share market adjusted in response to a collective downturn in global markets, with over 4,700 stocks declining [2]. - The trading volume in the two markets decreased to 1.8 trillion, with technology and brokerage sectors leading the declines, while automotive, consumer, and healthcare sectors also weakened [3][4]. Group 2: Reasons for Decline - The primary reasons for the A-share decline include a pullback in the global technology sector and unexpected negative news [5]. - The overnight drop in U.S. markets, particularly with Nvidia's revenue growth slowing down, contributed to negative sentiment across Asia-Pacific markets, including Japan, Hong Kong, and A-shares [5][6]. - The U.S. threat to impose additional tariffs on Chinese imports has also heightened market concerns, with China's Ministry of Commerce expressing strong opposition [7]. Group 3: Investment Strategy - Despite short-term market volatility, structural opportunities remain, and investors are advised to adjust strategies based on risk tolerance while seeking quality assets at lower prices [8]. - The upcoming National People's Congress (NPC) is expected to influence market trends, with historical data suggesting positive performance before the meetings and potential adjustments during the sessions [12][14]. Group 4: Sector Opportunities - Three main sectors are anticipated to benefit from potential policy support during the NPC: technology growth (focusing on AI and robotics), cyclical sectors (including infrastructure and real estate), and state-owned enterprise reforms [14][15][16]. - Historical analysis indicates that the market often experiences a rally leading up to the NPC, with a focus on small-cap stocks outperforming large-cap stocks [13].

证券研究报告 2025 年 02 月 18 日 湘财证券研究所 行业研究 中药行业周报 基层中医药覆盖面持续扩展，看好基层渗透率提升带来的需求增长 相关研究： 核心要点： ❑ 市场表现：上周中药Ⅱ上涨 0.8%，医药板块延续反弹态势 1. 《广东联盟中成药集采拟中 选结果公布，独家品种优势明显》 20250127 2. 《四成公司发布业绩预告， 2024行业业绩承压明显》 20250210 行业评级：增持（维持） 近十二个月行业表现 -20 -10 0 10 20 24/02 24/05 24/08 24/11 沪深300_累计 中药_累计 | % | 1 个月 | 3 个月 | 12 个月 | | --- | --- | --- | --- | | 相对收益 | -2 | -6 | -17 | | 绝对收益 | 1 | -4 | -4 | 注：相对收益与沪深 300 相比 分析师：许雯 证书编号：S0500517110001 Tel：(8621) 50293534 Email：xw3315@xcsc.com 地址：上海市浦东新区银城路88号 中国人寿金融中心10楼 上周（2025.02.10-2025.02 ...